Literature DB >> 5031561

Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.

T J Wiktor, H G Aaslestad, M M Kaplan.   

Abstract

Ionizing radiation, beta-propiolactone, and acetylethyleneimine were compared for their ability as virus-inactivating agents for the preparation of rabies vaccine. Each agent reduced viral infectivity exponentially; ionizing radiation also destroyed viral hemagglutinin. The vaccine prepared by ionizing radiation was equal or superior to that prepared by beta-propiolactone in its ability to protect mice from rabies infection. The acetylethyleneimine-treated vaccine was a less potent immunogen.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5031561      PMCID: PMC380470          DOI: 10.1128/am.23.5.914-918.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  12 in total

1.  ANTI-RABIES VACCINE OF TISSUE CULTURE ORIGIN.

Authors:  R E KISSLING; D R REESE
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

2.  Factors influencing inactivation of infectivity and hemagglutinin of influenza virus by gamma radiation.

Authors:  J R POLLEY
Journal:  Can J Microbiol       Date:  1961-08       Impact factor: 2.419

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  High intensity electrons as a tool for preparation of vaccines. I. Preparation of rabies vaccine.

Authors:  F B TRAUB; U FRIEDEMANN; A BRASCH; W HUBER
Journal:  J Immunol       Date:  1951-11       Impact factor: 5.422

5.  Inactivation of Venezuelan Equine Encephalomyelitis Virus by gamma-Radiation.

Authors:  M Reitman; H R Tribble
Journal:  Appl Microbiol       Date:  1967-11

6.  Antigenic and immunogenic properties of components contained in rabies virus-infected tissue culture fluids.

Authors:  H D Schlumberger; T J Wiktor; H Koprowski
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

7.  Viral subunits for rabies vaccination.

Authors:  J Crick; F Brown
Journal:  Nature       Date:  1969-04-05       Impact factor: 49.962

8.  Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin.

Authors:  T J Wiktor; F Sokol; E Kuwert; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

9.  Hemagglutination by rabies virus.

Authors:  E Kuwert; T J Wiktor; F Sokol; H Koprowski
Journal:  J Virol       Date:  1968-12       Impact factor: 5.103

10.  Reproducible plaquing system for rabies, lymphocytic choriomeningitis,k and other ribonucleic acid viruses in BHK-21-13S agarose suspensions.

Authors:  W D Sedwick; T J Wiktor
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

View more
  8 in total

1.  Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytes.

Authors:  P A Offit; H B Greenberg; K I Dudzik
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

2.  Inactivation of rabies virus in reagents used for the fluorescent rabies antibody test.

Authors:  L A White; W A Chappell
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

3.  Ethylenimine-inactivated rabies vaccine of tissue culture origin.

Authors:  O P Larghi; V L Savy; A E Nebel; A Rodriguez
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

4.  Sterility of gamma-irradiated pathogens: a new mathematical formula to calculate sterilizing doses.

Authors:  Eve V Singleton; Shannon C David; Justin B Davies; Timothy R Hirst; James C Paton; Michael R Beard; Farhid Hemmatzadeh; Mohammed Alsharifi
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

Review 5.  New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.

Authors:  Konstantin Chumakov; Ellie Ehrenfeld
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

6.  Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.

Authors:  T J Wiktor; R I Macfarlan; K J Reagan; B Dietzschold; P J Curtis; W H Wunner; M P Kieny; R Lathe; J P Lecocq; M Mackett
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production.

Authors:  O P Larghi; A E Nebel
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

Review 8.  Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.

Authors:  Fouad A Abolaban; Fathi M Djouider
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.